Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 29 Carcinoma, Hepatocellular 16 Prostatic Neoplasms 12 Neoplasm Metastasis 11 Carcinoma, Non-Small-Cell Lung 9 Neoplasms 8 Sarcoma 7 Osteosarcoma 6 Neuroendocrine Tumors 6 Brain Neoplasms 6 Urinary Bladder Neoplasms 5 Kidney Neoplasms 5 Carcinoma, Transitional Cell 5 Breast Neoplasms 5 Sarcoma, Ewing 4 Melanoma 4 Lung Neoplasms 4 Recurrence 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Carcinoid Tumor 3 Adrenocortical Carcinoma 3 Adenocarcinoma 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2 Urethral Neoplasms 2 Thyroid Neoplasms 2 Thyroid Diseases 2 Thyroid Cancer, Papillary 2

Interventions

epigallocatechin gallate 2 Ascorbic Acid 2 peflavit 1 microcrystalline cellulose 1 fisetin 1 cabozantinib 1 Temozolomide 1 Quercetin 1 Protons 1 Photons 1 Flavonoids 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Frailty × cabozantinib × Clear all

NCT04134390 2024-01-09

CABOMAYOR

Spanish Oncology Genito-Urinary Group

Phase 2 Completed

Frailty, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡